Nasdaq

Capricor Therapeutics Announces Successful FDA Pre-License Inspection and Upcoming Advisory Committee Meeting for Deramiocel in Duchenne Muscular Dystrophy Treatment

Capricor Therapeutics announced that it has successfully completed the U.S. FDA's Pre-License Inspection of its San Diego manufacturing facility for its lead therapy candidate, Deramiocel, aimed at ...
Hosted on MSN

FDA Completes Inspection of Capricor Therapeutics Manufacturing Facility For Deramiocel Approval: Retail Sees ‘Unimaginable Potential’

Shares of Capricor Therapeutics (CAPR) were in the spotlight on Wednesday morning after the company announced the completion of the U.S. Food and Drug Administration’s (FDA) Pre-License Inspection ...
Northwest Arkansas Democrat Gazette

FDA’s inspections still lag pre-pandemic period

WASHINGTON -- Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the covid-19 pandemic upended factory ...
Washington Times

Nearly 2,000 drug manufacturing plants overdue for FDA inspections after COVID delays, AP finds

WASHINGTON — Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory inspections ...